251 related articles for article (PubMed ID: 18658277)
1. Endothelial cell barrier protection by simvastatin: GTPase regulation and NADPH oxidase inhibition.
Chen W; Pendyala S; Natarajan V; Garcia JG; Jacobson JR
Am J Physiol Lung Cell Mol Physiol; 2008 Oct; 295(4):L575-83. PubMed ID: 18658277
[TBL] [Abstract][Full Text] [Related]
2. Magnitude-dependent effects of cyclic stretch on HGF- and VEGF-induced pulmonary endothelial remodeling and barrier regulation.
Birukova AA; Moldobaeva N; Xing J; Birukov KG
Am J Physiol Lung Cell Mol Physiol; 2008 Oct; 295(4):L612-23. PubMed ID: 18689603
[TBL] [Abstract][Full Text] [Related]
3. Rac and Rho play opposing roles in the regulation of hypoxia/reoxygenation-induced permeability changes in pulmonary artery endothelial cells.
Wojciak-Stothard B; Tsang LY; Haworth SG
Am J Physiol Lung Cell Mol Physiol; 2005 Apr; 288(4):L749-60. PubMed ID: 15591411
[TBL] [Abstract][Full Text] [Related]
4. Deciphering the signaling networks underlying simvastatin-induced apoptosis in human cancer cells: evidence for non-canonical activation of RhoA and Rac1 GTPases.
Zhu Y; Casey PJ; Kumar AP; Pervaiz S
Cell Death Dis; 2013 Apr; 4(4):e568. PubMed ID: 23559002
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin Ameliorates Matrix Stiffness-Mediated Endothelial Monolayer Disruption.
Lampi MC; Faber CJ; Huynh J; Bordeleau F; Zanotelli MR; Reinhart-King CA
PLoS One; 2016; 11(1):e0147033. PubMed ID: 26761203
[TBL] [Abstract][Full Text] [Related]
6. Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice.
Vecchione C; Brandes RP
Circ Res; 2002 Jul; 91(2):173-9. PubMed ID: 12142351
[TBL] [Abstract][Full Text] [Related]
7. Cytoskeletal activation and altered gene expression in endothelial barrier regulation by simvastatin.
Jacobson JR; Dudek SM; Birukov KG; Ye SQ; Grigoryev DN; Girgis RE; Garcia JG
Am J Respir Cell Mol Biol; 2004 May; 30(5):662-70. PubMed ID: 14630613
[TBL] [Abstract][Full Text] [Related]
8. Crucial role of membrane type 1 matrix metalloproteinase (MT1- MMP) in RhoA/Rac1-dependent signaling pathways in thrombin- stimulated endothelial cells.
Ando K; Ishibashi T; Ohkawara H; Inoue N; Sugimoto K; Uekita H; Hu C; Okamoto Y; Takuwa Y; Takeishi Y
J Atheroscler Thromb; 2011; 18(9):762-73. PubMed ID: 21628952
[TBL] [Abstract][Full Text] [Related]
9. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA.
Park HJ; Kong D; Iruela-Arispe L; Begley U; Tang D; Galper JB
Circ Res; 2002 Jul; 91(2):143-50. PubMed ID: 12142347
[TBL] [Abstract][Full Text] [Related]
10. Extracellular beta-nicotinamide adenine dinucleotide (beta-NAD) promotes the endothelial cell barrier integrity via PKA- and EPAC1/Rac1-dependent actin cytoskeleton rearrangement.
Umapathy NS; Zemskov EA; Gonzales J; Gorshkov BA; Sridhar S; Chakraborty T; Lucas R; Verin AD
J Cell Physiol; 2010 Apr; 223(1):215-23. PubMed ID: 20054824
[TBL] [Abstract][Full Text] [Related]
11. Driving Rho GTPase activity in endothelial cells regulates barrier integrity.
Beckers CM; van Hinsbergh VW; van Nieuw Amerongen GP
Thromb Haemost; 2010 Jan; 103(1):40-55. PubMed ID: 20062930
[TBL] [Abstract][Full Text] [Related]
12. Impact of HMG CoA reductase inhibition on small GTPases in the heart.
Laufs U; Kilter H; Konkol C; Wassmann S; Böhm M; Nickenig G
Cardiovasc Res; 2002 Mar; 53(4):911-20. PubMed ID: 11922901
[TBL] [Abstract][Full Text] [Related]
13. Endothelial cell barrier enhancement by ATP is mediated by the small GTPase Rac and cortactin.
Jacobson JR; Dudek SM; Singleton PA; Kolosova IA; Verin AD; Garcia JG
Am J Physiol Lung Cell Mol Physiol; 2006 Aug; 291(2):L289-95. PubMed ID: 16825658
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivation.
Singleton PA; Moreno-Vinasco L; Sammani S; Wanderling SL; Moss J; Garcia JG
Am J Respir Cell Mol Biol; 2007 Aug; 37(2):222-31. PubMed ID: 17395891
[TBL] [Abstract][Full Text] [Related]
15. Differential endothelial hydrogen peroxide signaling via Nox isoforms: Critical roles for Rac1 and modulation by statins.
Waldeck-Weiermair M; Yadav S; Kaynert J; Thulabandu VR; Pandey AK; Spyropoulos F; Covington T; Das AA; Krüger C; Michel T
Redox Biol; 2022 Dec; 58():102539. PubMed ID: 36401888
[TBL] [Abstract][Full Text] [Related]
16. Effects of statins on endothelium and signaling mechanisms.
Endres M; Laufs U
Stroke; 2004 Nov; 35(11 Suppl 1):2708-11. PubMed ID: 15375300
[TBL] [Abstract][Full Text] [Related]
17. PKA inhibits RhoA activation: a protection mechanism against endothelial barrier dysfunction.
Qiao J; Huang F; Lum H
Am J Physiol Lung Cell Mol Physiol; 2003 Jun; 284(6):L972-80. PubMed ID: 12588708
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandins PGE(2) and PGI(2) promote endothelial barrier enhancement via PKA- and Epac1/Rap1-dependent Rac activation.
Birukova AA; Zagranichnaya T; Fu P; Alekseeva E; Chen W; Jacobson JR; Birukov KG
Exp Cell Res; 2007 Jul; 313(11):2504-20. PubMed ID: 17493609
[TBL] [Abstract][Full Text] [Related]
19. Angiopoietin-1 requires p190 RhoGAP to protect against vascular leakage in vivo.
Mammoto T; Parikh SM; Mammoto A; Gallagher D; Chan B; Mostoslavsky G; Ingber DE; Sukhatme VP
J Biol Chem; 2007 Aug; 282(33):23910-8. PubMed ID: 17562701
[TBL] [Abstract][Full Text] [Related]
20. HGF attenuates thrombin-induced endothelial permeability by Tiam1-mediated activation of the Rac pathway and by Tiam1/Rac-dependent inhibition of the Rho pathway.
Birukova AA; Alekseeva E; Mikaelyan A; Birukov KG
FASEB J; 2007 Sep; 21(11):2776-86. PubMed ID: 17428964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
